Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
![]()
Reuters NewMedia, Inc. - Thursday September 11 8:48 PM EDT
Maggie Fox, Health and Science Correspondent
They said human herpesvirus 8 (HHV-8) had surrendered secrets about how it steals a gene from its human victim and uses it to invade cells in an act of "molecular piracy".
Thue Schwartz of the University of Copenhagen in Denmark and a team of international colleagues, working with Glaxo-Wellcome (GLXO.L), found the virus produces vMIP-II, a protein that looks like a chemokine.
Chemokines are signalling chemicals involved in immune response and known to be important to understanding how HIV works. HIV often uses the same receptors, or chemical doorways into cells, as chemokines use.
Writing in the journal Science, they said vMIP-II acts as a blocking agent, binding to chemokine receptors and preventing white blood cells from being attracted to the site of infection.
"Because vMIP-II could inhibit cell entry of human immunodeficiency virus (HIV) ... this protein may serve as a lead for development of broad-spectrum anti-HIV agents," they wrote.
"No known human chemokine has as broad a spectrum of activities as vMIP-II," they added.
Some of the receptors the vMIP-II blocks are CCR5 and CXCR4, known to be used by HIV. Recent research has found that different strains of HIV attach to different receptors, and the virus may switch to different receptors as it mutates.
Glaxo said in a statement that the biological process used by the HHV-8 virus to make vMIP-II was similar to standard drug discovery methods.
"The hope is that by understanding how the virus made this antagonist, we will learn lessons which will help us in the design of our own drugs," said Tim Wells of Glaxo's Institute of Biomedical Research in Geneva.
"vMIP-II will help us understand the structural differences between these two types of receptors and may lead to the discovery of a small molecule that would block both receptors," Well added.
HHV-8 cause Kaposi's sarcoma, a once-rare form of cancer that is now one of the marker diseases for AIDS. The virus is a relative of the viruses that cause genital herpes and cold sores.
Glaxo said HHV-8 was probably using the chemokine to shut off the inflammatory response normally associated with a tumor, which means it could also be useful against inflammatory diseases such as rheumatoid arthritis or asthma.
970911
RE970905
Copyright © 1997 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .